AAPL   322.16 (+1.03%)
MSFT   185.22 (+0.93%)
FB   240.18 (+2.24%)
GOOGL   1,440.68 (+1.94%)
AMZN   2,454.38 (+0.64%)
NVDA   362.80 (+0.38%)
CGC   20.64 (+5.47%)
BABA   205.95 (+3.13%)
TSLA   827.26 (+1.27%)
AMD   55.88 (+0.81%)
T   30.71 (+2.78%)
ACB   15.58 (-2.68%)
F   5.92 (+4.60%)
GILD   72.97 (-0.50%)
NFLX   423.47 (-1.36%)
BAC   23.87 (+5.34%)
BA   144.21 (+4.86%)
AAPL   322.16 (+1.03%)
MSFT   185.22 (+0.93%)
FB   240.18 (+2.24%)
GOOGL   1,440.68 (+1.94%)
AMZN   2,454.38 (+0.64%)
NVDA   362.80 (+0.38%)
CGC   20.64 (+5.47%)
BABA   205.95 (+3.13%)
TSLA   827.26 (+1.27%)
AMD   55.88 (+0.81%)
T   30.71 (+2.78%)
ACB   15.58 (-2.68%)
F   5.92 (+4.60%)
GILD   72.97 (-0.50%)
NFLX   423.47 (-1.36%)
BAC   23.87 (+5.34%)
BA   144.21 (+4.86%)
AAPL   322.16 (+1.03%)
MSFT   185.22 (+0.93%)
FB   240.18 (+2.24%)
GOOGL   1,440.68 (+1.94%)
AMZN   2,454.38 (+0.64%)
NVDA   362.80 (+0.38%)
CGC   20.64 (+5.47%)
BABA   205.95 (+3.13%)
TSLA   827.26 (+1.27%)
AMD   55.88 (+0.81%)
T   30.71 (+2.78%)
ACB   15.58 (-2.68%)
F   5.92 (+4.60%)
GILD   72.97 (-0.50%)
NFLX   423.47 (-1.36%)
BAC   23.87 (+5.34%)
BA   144.21 (+4.86%)
AAPL   322.16 (+1.03%)
MSFT   185.22 (+0.93%)
FB   240.18 (+2.24%)
GOOGL   1,440.68 (+1.94%)
AMZN   2,454.38 (+0.64%)
NVDA   362.80 (+0.38%)
CGC   20.64 (+5.47%)
BABA   205.95 (+3.13%)
TSLA   827.26 (+1.27%)
AMD   55.88 (+0.81%)
T   30.71 (+2.78%)
ACB   15.58 (-2.68%)
F   5.92 (+4.60%)
GILD   72.97 (-0.50%)
NFLX   423.47 (-1.36%)
BAC   23.87 (+5.34%)
BA   144.21 (+4.86%)
Log in

NASDAQ:LGNDLigand Pharmaceuticals Price Target & Analyst Ratings

$108.64
+2.66 (+2.51 %)
(As of 05/26/2020 09:29 AM ET)
Add
Compare
Today's Range
$104.59
Now: $108.64
$108.88
50-Day Range
$73.23
MA: $95.12
$108.64
52-Week Range
$57.24
Now: $108.64
$122.08
Volume202,542 shs
Average Volume368,920 shs
Market Capitalization$1.74 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.6

Analyst Ratings

Ligand Pharmaceuticals (NASDAQ:LGND) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
6 Wall Street analysts have issued ratings and price targets for Ligand Pharmaceuticals in the last 12 months. Their average twelve-month price target is $163.20, suggesting that the stock has a possible upside of 50.22%. The high price target for LGND is $229.00 and the low price target for LGND is $132.00. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.673.003.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $163.20$163.20$164.80$166.50
Price Target Upside: 50.22% upside108.62% upside73.27% upside67.72% upside

Ligand Pharmaceuticals (NASDAQ:LGND) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Ligand Pharmaceuticals (NASDAQ:LGND) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/8/2020HC WainwrightLower Price Target$237.00 ➝ $229.00High
3/24/2020ArgusDowngradeBuy ➝ HoldHigh
3/9/2020GuggenheimInitiated CoverageNeutralHigh
2/28/2020BenchmarkReiterated RatingBuy$135.00High
2/10/2020Roth CapitalLower Price TargetBuy$185.00 ➝ $180.00Medium
9/19/2019BarclaysUpgradeEqual Weight ➝ Overweight$110.00 ➝ $132.00High
8/17/2018Goldman Sachs GroupInitiated CoverageNeutral$256.00High
8/8/2018StephensReiterated RatingBuy$248.00High
8/7/2018Craig HallumBoost Price TargetBuy$230.00 ➝ $260.00Medium
11/20/2017Deutsche BankDowngradeHold ➝ Sell$105.00N/A
(Data available from 5/26/2018 forward)
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.